Finally, the mechanism that we propose for the activation of IRX3 in AML cannot explain how this transcription factor gene is so highly expressed in around 50% of cases of T-acute lymphoblastic leukemia, where expression of FTO-lncAML is not observed. The gene discussed is FTO; the disease is acute myeloid leukemia.